Back to Results
First PageMeta Content
European Federation of Pharmaceutical Industries and Associations / Pharmaceutical industry


Luk A. Maes Adaptive Pathways in Licensing and Market Access (Additional Evidence Generation for Health Technologies) In the European Union (EU), the current Adaptive Pathways (AP)1 discussions are part of the Commission
Add to Reading List

Document Date: 2016-08-09 12:59:24


Open Document

File Size: 309,86 KB

Share Result on Facebook